Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma

被引:13
|
作者
Mundada, Pravin [1 ]
Varoquaux, Arthur Damien [2 ]
Lenoir, Vincent [1 ]
de Vito, Claudio [3 ]
Dulguerov, Nicolas [4 ]
Ailianou, Angeliki [1 ,6 ]
Caparrotti, Francesca [5 ]
Becker, Minerva [1 ]
机构
[1] Univ Geneva, Geneva Univ Hosp, Div Radiol, Dept Imaging & Med Informat, Geneva, Switzerland
[2] Aix Marseille Med Univ, Ctr Magnet Resonance Biol & Med, Marseille, France
[3] Univ Geneva, Geneva Univ Hosp, Dept Lab Med Genet & Pathol, Div Clin Pathol, Geneva, Switzerland
[4] Univ Geneva, Geneva Univ Hosp, Dept Clin Neurosci, Clin Otorhinolaryngol Head & Neck Surg, Geneva, Switzerland
[5] Geneva Univ Hosp, Dept Oncol, Div Radiat Oncol, Geneva, Switzerland
[6] Hosp Neuchatel, Dept Imaging, Div Radiol, Neuchatel, Switzerland
关键词
Head and neck squamous cell carcinoma; Post-treatment loco-regional failure; Lymph node recurrence; Diffusion weighted imaging; MRI; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; RADIATION TREATMENT; FOLLOW-UP; CHEMORADIOTHERAPY; CANCER; TUMORS; RADIOTHERAPY; METAANALYSIS; METASTASIS;
D O I
10.1016/j.ejrad.2018.02.026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To determine the diagnostic performance of morphologic MRI with diffusion weighted imaging (DWIMRI) for the detection of post-treatment lymph node (LN) recurrence of head and neck squamous cell carcinoma (HNSCC). Methods: This retrospective study is based on 33 HNSCC patients who underwent DWIMRI with apparent diffusion coefficient (ADC) measurements for suspected post-treatment loco-regional failure. Two radiologists, blinded to clinical/histopathological data, analyzed MR images according to established morphologic criteria and measured ADC values by drawing regions of interest on each normal/abnormal looking lymph node (LN). Histopathological findings in 40 neck dissections, 133 LN-levels and 755 LNs served as gold standard. Results: Malignant LNs had lower ADCmean values than benign LNs (1.15 +/- 0.35x10(-3) mm(2)/s versus 1.28 +/- 0.28x10(-3) mm(2)/s, p = .028). The optimal ADCmean threshold to differentiate malignant from benign LNs was 1.1695x10(-3) mm(2)/s. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values (95% CI in parentheses) of DWIMRI with morphologic criteria and ADCmean<1.1695x10(-3)mm(2)/s were: (a) 100%(86.2; 100), 44.4%(15.3; 77.3), 86.1%(69.7; 94.7), and 100%(39.5; 100) per neck dissection; (b) 83.6%(69.7; 92.2), 91.6%(83.0; 96.2), 85.4%(71.6; 93.4), and 90.5%(81.7; 95.5) per LN-level; (c) 53.1%(43.5; 62.4), 95.5%(93.5; 96.9), 67.4%(56.6; 76.7), and 92.0%(89.6; 93.9) per LN, respectively. Conclusion: The high NPV of DWIMRI irrespective of analysis type (per neck dissection/per neck level/per lymph node) make it a useful follow-up tool after treatment.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 50 条
  • [41] Head and neck squamous cell carcinoma (HNSCC): Comparison between SUV max in FDG-PET/CT and CDA with diffusion-weighted MRI for nodal involvement
    Rousset, Jean
    Tissot, Valentin
    Abgral, Ronan
    Le Roux, Pierre-Yves
    Valette, Gerald
    Conan-Charlet, Virginie
    Marianowski, Remi
    Nonent, Michel
    Salaun, Pierre
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [42] Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect
    Hiroki Kato
    Masayuki Kanematsu
    Osamu Tanaka
    Keisuke Mizuta
    Mitsuhiro Aoki
    Toshiyuki Shibata
    Tomomi Yamashita
    Yoshinobu Hirose
    Hiroaki Hoshi
    European Radiology, 2009, 19 : 103 - 109
  • [43] Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma
    Vincent Vandecaveye
    Piet Dirix
    Frederik De Keyzer
    Katya Op de Beeck
    Vincent Vander Poorten
    I. Roebben
    Sandra Nuyts
    Robert Hermans
    European Radiology, 2010, 20 : 1703 - 1714
  • [44] Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma
    Vandecaveye, Vincent
    Dirix, Piet
    De Keyzer, Frederik
    Op de Beeck, Katya
    Vander Poorten, Vincent
    Roebben, I.
    Nuyts, Sandra
    Hermans, Robert
    EUROPEAN RADIOLOGY, 2010, 20 (07) : 1703 - 1714
  • [45] Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect
    Kato, Hiroki
    Kanematsu, Masayuki
    Tanaka, Osamu
    Mizuta, Keisuke
    Aoki, Mitsuhiro
    Shibata, Toshiyuki
    Yamashita, Tomomi
    Hirose, Yoshinobu
    Hoshi, Hiroaki
    EUROPEAN RADIOLOGY, 2009, 19 (01) : 103 - 109
  • [46] DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING EARLY AFTER CHEMORADIOTHERAPY TO MONITOR TREATMENT RESPONSE IN HEAD-AND-NECK SQUAMOUS CELL CARCINOMA
    Vandecaveye, Vincent
    Dirix, Piet
    De Keyzer, Frederik
    de Beeck, Katya Op
    Vander Poorten, Vincent
    Hauben, Esther
    Lambrecht, Maarten
    Nuyts, Sandra
    Hermans, Robert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1098 - 1107
  • [47] IS WHOLE BODY SCANNING NECESSARY IN STAGING AND POST-TREATMENT PET/CT FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS?
    Hsiao, Edward
    Nguyen, Duy
    Aslani, Ali
    Schembri, Geoffrey
    Roach, Paul
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 5 - 6
  • [48] Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: Role of magnetic resonance imaging
    Lin, Doris
    Glastonbury, Christine M.
    Rafaelian, Olga
    Eisele, David W.
    Wang, Steven J.
    JOURNAL OF OTOLARYNGOLOGY, 2007, 36 (06): : 350 - 356
  • [49] A Random Forest Model for Post-Treatment Survival Prediction in Patients with Non-Squamous Cell Carcinoma of the Head and Neck
    Zhang, Xin
    Liu, Guihong
    Peng, Xingchen
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [50] Diagnostic accuracy of diffusion-weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site
    Fong, Devin
    Bhatia, Kunwar S. S.
    Yeung, David
    King, Ann D.
    ORAL ONCOLOGY, 2010, 46 (08) : 603 - 606